• Perguntas frequentes
  • Glossário
Fechar

Perguntas frequentes

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Ver todas as FAQs

Fechar

Glossário

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Ver o glossário completo

Voltar ao índice do glossário

Marketing authorisation under exceptional circumstances

Specific approval for certain medicines targeting rare diseases or when full data collection is unethical or impossible.

Read related content in the entries on Marketing authorisation under exceptional circumstances of the research pathways.

Voltar ao topo
Achou o conteúdo desta página útil? Se não, pode deixar-nos uma mensagem para que possamos melhorar Envie-nos as suas ideias